Genomics has the potential to help improve outcomes for people with cancer, and the journey to mainstreaming genomic testing for cancer patients in the NHS is underway. In October this year, the national genomic testing directory will be introduced in England which will set out the genomic testing available and the clinical indications for its use. From October, for a small number of cancer types, NHS patients will be offered whole genome sequencing for the first time, together with the introduction of more extensive gene panel testing. The introduction of these tests will require new ways of handling and processing tissue to get the best possible outcomes for patients.
To support implementation NHS England and Genomics England in partnership with Cancer Research UK and Macmillan, are inviting colleagues from the cancer community to join one of 4 regional events being held across the country this spring. The 4 regional events are open to all patients, clinicians and key partners who are passionate about improving care in cancer.
For more information, details on dates/venues and to register click here